Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 38 Neoplasm Metastasis 14 Liver Neoplasms 11 Colorectal Neoplasms 11 Cholangiocarcinoma 9 Pancreatic Neoplasms 8 Lung Neoplasms 8 Colonic Neoplasms 7 Breast Neoplasms 7 Thyroid Nodule 6 Recurrence 6 Carcinoma, Renal Cell 6 Carcinoma, Non-Small-Cell Lung 6 Thyroid Neoplasms 5 Rectal Neoplasms 4 Neoplasms 4 Esophageal Neoplasms 4 Prostatic Neoplasms 3 Pain 3 Kidney Neoplasms 3 Barrett Esophagus 3 Agnosia 3 Thyroid Diseases 2 Thyroid Cancer, Papillary 2 Leiomyoma 2 Hyperaldosteronism 2 Gallbladder Neoplasms 2 Cancer Pain 2 Bile Duct Neoplasms 2 Adrenocortical Adenoma 2

Interventions

Sorafenib 2 nimotuzumab 1 lenvatinib 1 atezolizumab 1 Stents 1 Radiotherapy 1 Radiosurgery 1 Radiofrequency Ablation 1 Immune Checkpoint Inhibitors 1 Hematologic Tests 1 Ethiodized Oil 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × HCC × Radiofrequency Ablation × Clear all

NCT01470495 2017-03-28

REPEAT

Southwest Hospital, China

Phase NA Unknown

HCC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡